APLS logo

Apellis Pharmaceuticals (APLS) Depreciation and amortization

annual D&A:

$1.80M+$13.00K(+0.73%)
December 31, 2024

Summary

  • As of today (July 1, 2025), APLS annual depreciation & amortization is $1.80 million, with the most recent change of +$13.00 thousand (+0.73%) on December 31, 2024.
  • During the last 3 years, APLS annual D&A has risen by +$305.00 thousand (+20.44%).
  • APLS annual D&A is now at all-time high.

Performance

APLS Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

quarterly D&A:

$446.00K-$8000.00(-1.76%)
March 31, 2025

Summary

  • As of today (July 1, 2025), APLS quarterly depreciation & amortization is $446.00 thousand, with the most recent change of -$8000.00 (-1.76%) on March 31, 2025.
  • Over the past year, APLS quarterly D&A has increased by +$2000.00 (+0.45%).
  • APLS quarterly D&A is now -28.18% below its all-time high of $621.00 thousand, reached on September 30, 2024.

Performance

APLS quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

TTM D&A:

$1.80M+$2000.00(+0.11%)
March 31, 2025

Summary

  • As of today (July 1, 2025), APLS TTM depreciation & amortization is $1.80 million, with the most recent change of +$2000.00 (+0.11%) on March 31, 2025.
  • Over the past year, APLS TTM D&A has dropped by -$30.00 thousand (-1.64%).
  • APLS TTM D&A is now -5.96% below its all-time high of $1.91 million, reached on September 30, 2024.

Performance

APLS TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

APLS Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.7%+0.5%-1.6%
3 y3 years+20.4%+23.9%+23.4%
5 y5 years+201.5%+214.1%+188.3%

APLS Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+20.4%-28.2%+60.4%-6.0%+33.1%
5 y5-yearat high+201.5%-28.2%+265.6%-6.0%+188.3%
alltimeall timeat high>+9999.0%-28.2%>+9999.0%-6.0%>+9999.0%

APLS Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$446.00K(-1.8%)
$1.80M(+0.1%)
Dec 2024
$1.80M(+0.7%)
$454.00K(-26.9%)
$1.80M(-6.1%)
Sep 2024
-
$621.00K(+123.4%)
$1.91M(+12.7%)
Jun 2024
-
$278.00K(-37.4%)
$1.70M(-7.2%)
Mar 2024
-
$444.00K(-22.1%)
$1.83M(+2.5%)
Dec 2023
$1.78M(+14.9%)
$570.00K(+40.7%)
$1.78M(+4.5%)
Sep 2023
-
$405.00K(-1.2%)
$1.71M(+2.9%)
Jun 2023
-
$410.00K(+2.8%)
$1.66M(+4.3%)
Mar 2023
-
$399.00K(-19.1%)
$1.59M(+2.5%)
Dec 2022
$1.55M(+4.0%)
$493.00K(+38.1%)
$1.55M(+8.2%)
Sep 2022
-
$357.00K(+4.4%)
$1.44M(+6.1%)
Jun 2022
-
$342.00K(-5.0%)
$1.35M(-7.3%)
Mar 2022
-
$360.00K(-4.3%)
$1.46M(-2.3%)
Dec 2021
$1.49M
$376.00K(+37.2%)
$1.49M(+6.9%)
Sep 2021
-
$274.00K(-38.8%)
$1.40M(-2.9%)
Jun 2021
-
$448.00K(+13.7%)
$1.44M(+29.3%)
DateAnnualQuarterlyTTM
Mar 2021
-
$394.00K(+40.7%)
$1.11M(+29.3%)
Dec 2020
$859.00K(+44.1%)
$280.00K(-11.1%)
$859.00K(+8.1%)
Sep 2020
-
$315.00K(+158.2%)
$795.00K(+27.4%)
Jun 2020
-
$122.00K(-14.1%)
$624.00K(0.0%)
Mar 2020
-
$142.00K(-34.3%)
$624.00K(+4.7%)
Dec 2019
$596.00K(>+9900.0%)
$216.00K(+50.0%)
$596.00K(+56.8%)
Sep 2019
-
$144.00K(+18.0%)
$380.00K(+61.0%)
Jun 2019
-
$122.00K(+7.0%)
$236.00K(+107.0%)
Mar 2019
-
$114.00K(>+9900.0%)
$114.00K(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00
Dec 2017
$0.00(-100.0%)
-
-
Dec 2014
$6600.00(+4.8%)
-
-
Dec 2013
$6300.00
-
-

FAQ

  • What is Apellis Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual D&A year-on-year change?
  • What is Apellis Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly D&A year-on-year change?
  • What is Apellis Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals TTM D&A year-on-year change?

What is Apellis Pharmaceuticals annual depreciation & amortization?

The current annual D&A of APLS is $1.80M

What is the all time high annual D&A for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual depreciation & amortization is $1.80M

What is Apellis Pharmaceuticals annual D&A year-on-year change?

Over the past year, APLS annual depreciation & amortization has changed by +$13.00K (+0.73%)

What is Apellis Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of APLS is $446.00K

What is the all time high quarterly D&A for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly depreciation & amortization is $621.00K

What is Apellis Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, APLS quarterly depreciation & amortization has changed by +$2000.00 (+0.45%)

What is Apellis Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of APLS is $1.80M

What is the all time high TTM D&A for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high TTM depreciation & amortization is $1.91M

What is Apellis Pharmaceuticals TTM D&A year-on-year change?

Over the past year, APLS TTM depreciation & amortization has changed by -$30.00K (-1.64%)
On this page